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ABSTRACT
Objective: The current study was aimed to evaluate the methanolic extract of caryopses of Echinochloa colona (ECME) for its in vitro hepatoprotective 
activity against ethanol in HepG2 cell lines.
Methods: In this regard, the cytotoxicity studies were conducted for the extract, ECME using 3-(4,5-dimethythiazol- 2-yl)-2,5-diphenyl tetrazolium 
bromide assay to determine the inhibitory concentration 50% value based on which, the doses 50, 100, and 200 µg/ml were selected for the 
hepatoprotective studies in HepG2 cell lines. The toxicity was induced using ethanol (100 mM). The in vitro hepatoprotective activity of the extract 
was assessed based on the changes in the level of biochemical parameters such as aspartate aminotransferase, alanine aminotransferase, and lactate 
dehydrogenase.
Results: The extract, ECME has shown a dose-dependent cytoprotective activity with maximum protection at 200 µg/ml. The percentage cell viability 
of the extract, ECME at 200 µg/ml was more, i.e., 69.33% which was well comparable to that of standard drug, silymarin (100 µg/ml).
Conclusion: The study revealed that the extract had shown significant hepatoprotective activity at all the test doses against ethanol-induced cytotoxity 
assay.
Keywords: Ethanol, HepG2, Hepatoprotective activity, Echinochloa colona, 3-(4,5-dimethythiazol- 2-yl)-2,5-diphenyl tetrazolium bromide.
INTRODUCTION
Liver disorders are recognized as one of the serious global health 
problems occurring due to the adoption of modern food styles as well 
as exposure to many environmental pollutants and excessive intake of 
some drugs. According to the World Health Organization, liver cirrhosis 
is the 8th leading cause of death in the United States and 13th leading 
cause of death globally, with worldwide mortality having increased by 
45.6% from 1990 to 2013 due to alcohol-induced liver cirrhosis [1]. The 
studies in animal models suggest that liver injury in chronic alcoholics is 
due to oxidative stress that leads to fibrosis and impaired liver functions 
and increased apoptosis [2]. Herbal medicines are believed to be much 
safer and proved elixir in the treatment of various ailments such as 
diabetes, liver disorders, central nervous system, and disorders [3]. It 
is estimated that about 80% of the population of developing countries 
relies on traditional medicines, mostly plant drugs and for their primary 
health-care needs [4]. In India, more than 93 medicinal plants are used 
in different combinations in the preparations of 40 patented herbal 
formulations. However, only a small proportion of hepatoprotective 
plants used in traditional medicine are pharmacologically evaluated for 
their safety and efficacy, and many are yet to be investigated [5]. Hence, 
there is a great need for identification of such plants for scientific 
pharmacological investigation.
The plant Echinochloa colona of family Graminae, is significant 
medicinally and claimed to be useful in the treatment of various 
ailments such as fever, diabetes, and jaundice. There are no reports on 
the scientific validation of its traditional medicinal claim. In view of this, 
an attempt has been made in the present investigation to develop an 
herbal drug in the treatment of liver disorders. Therefore, the present 
study was designed to evaluate its traditional claim in the treatment of 
liver disorders using HepG2 cell lines in vitro.
HepG2 cells are a suitable in vitro model system for the study of human 
liver diseases that are caused by xenobiotic metabolism and other 
chemicals that cause toxicity to liver [6]. The objective of the present 
work is to investigate the methanolic extract of caryopses of E. colona 
(ECME) for its in vitro hepatoprotective activity against ethanol using 
HepG2 cell lines.
METHODS
Collection and preparation of extracts
The caryopses of E. colona were collected in the month of July 2012, from 
rice fields of Pedda Pendial, Warangal district, Telangana state, India, 
after its authentication by Prof. V.S. Raju, Department of Botany, Kakatiya 
University, Warangal. The material was washed under tap water and 
shade dried, coarsely powdered (800 g) and macerated with methanol 
in a round bottom flask for 7 days with intermittent stirring and filtered 
after 7 days and concentrated under reduced pressure to yield a green 
semi-solid mass. The percentage yield of the extract was found to be 5.8%.
Drugs and chemicals
HepG2 Cell lines were obtained from National Centre for Cell Sciences, 
Pune India. The drugs and chemicals were purchased from various 
companies and the details are as follows: Dulbecco’s modified eagles 
medium, silymarin - Sigma Aldrich, Spruce Street, St. Louis, China; FC 
reagent, Biochemical kits - Merck Specialties Private Limited, Mumbai, 
India; fetal bovine serum was purchased from Himedia laboratories, 
Mumbai, India; Ethanol - Changshu Yangyuan Chemicals, China. All 
other chemicals and solvents used were of analytical grade.
Phytochemical analysis
The ECME was subjected to chemical tests for detection of various 
phytoconstituents such as saponins, steroid/triterpenoidal, flavonoidal 
compounds and their glycosides, alkaloids, phenolics, and tannins [7].
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Determination of total phenolic content
The total phenolic content in ECME was determined using 
Folin–Ciocalteu reagent according to the method of Marinova et al. [8] 
with minor modifications. It was carried out in triplicate and expressed 
as gallic acid equivalents in mg per gram of extract.
Determination of total flavonoid content
The total flavonoid content in ECME was determined using aluminium 
chloride assay following the method of Marinova et al. [8] and was 
performed in triplicate and expressed as rutin equivalents (RE) in mg 
per gram of extract.
Determination of in vitro cytotoxic activity
The 50% cytotoxic concentration CTC 50 was determined by 
estimating mitochondrial synthesis using tetrazolium assay [9]. 
HepG2 cells (5.0 × 103 cells/well) were maintained in 96 well culture 
plate for 72 hrs in presence of 100 µl of ECME at the concentrations 
of 10, 30, 100, 300, 1000, and 3000 µg/ml. At the end of incubation 
period, the drug solutions in the wells were discarded and 50 µl of 
3-(4,5-dimethythiazol- 2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
prepared in modified Eagle’s medium (MEM) without phenol red was 
added in each well. The plates were gently shaken and incubated for 
3 hrs at 37°C in 5% CO2 atmosphere. After 3 hrs, the supernatant was 
removed. Later on, 50 µl of propanol was added, and the plates were 
gently shaken to solubilize the formed formazan followed by 30 min 
incubation at room temperature with constant shaking. Absorbance 
(optical density [OD]) was read at 540 nm using microplate reader (Bio-
Tek Instruments, Inc., Winooski, VT). The percentage growth inhibition 
was calculated using the following formula:
% Growth inhibition = (Mean OD of normal control − Mean OD of test 
group/Mean OD of Normal control) × 100
A dose-response curve was generated using % growth inhibition on 
Y axis and the extract concentration (µg/ml) on X-axis. The CTC 50 
value is calculated from dose-response curve.
Assessment of hepatoprotective activity of ECME in vitro
The hepatoprotective activity of ECME was evaluated using well-
maintained HepG2 cells. Ethanol was used as hepatotoxicant and 
silymarin was used as a standard positive control. The toxic concentration 
of ethanol taken was 100 mM. The choice of concentrations of ECME and 
standard was based on the results of the MTT assay. The experimental 
groups were carried out in triplicate as follows:
1. Group I (Control):
• Normal control: The cells were treated with100 µl of serum-free 
culture medium for 24 hrs.
• Dimethyl sulfoxide (DMSO) control: The cells were treated 
with 100 µl of serum-free culture medium containing DMSO 
(0.3% v/v) for 24 hrs.
• Silymarin control: The cells were treated with 100 µl of serum-
free culture medium containing silymarin (200 µg/ml) for 24 hrs.
• ECME control: The cells were treated with 100 µl of serum-free 
culture medium containing ECME (200 µg/ml) for 24 hrs.
2. Group II (toxin treatment): The cells were treated with 100 µl of 
serum-free culture medium containing 100 mM ethanol for 24 hrs.
3. Group III (silymarin treatment): The cells were treated with 100 µl 
of serum-free culture medium containing 100 mM ethanol with 
silymarin at a concentration of 50 and 100 µg/ml for 24 hrs.
4. Group IV (ECME treatment): The cells were treated with 100 µl of 
serum-free culture medium containing 100 mM ethanol with ECME 
at a concentration of 50, 100, and 200 µg/ml for 24 hrs. Later, cell 
viability, aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), and lactate dehydrogenase (LDH) leakage assays were 
performed for all groups according to the standard method [6] using 
Ecoline diagnostic kits.
Statistical analysis
The data obtained were analyzed by one-way ANOVA followed by 
Dunnett’s multiple comparisons test using the Graph pad prism 
version 4 (Graph Pad Software, La Jolla California USA).
RESULTS AND DISCUSSION
It is well known that plants or their extracts contain a number 
of chemicals belonging to different classes. Most of them are of 
pharmacological importance such as flavonoids, steroids, triterpenoids, 
and their glycosides, alkaloids [10]. Hence, preliminary phytochemical 
screening of the extract, ECME was carried out. The preliminary 
investigation on the ECME revealed that it contains chemical 
constituents of pharmacological significance such as steroidal/
triterpenoidal and flavonoidal glycosides, saponins, and phenolic 
compounds. The flavonoidal and phenolic compounds play an 
important role in culminating the oxidative stress produced by reactive 
oxygen species and hydroxyl radicals generated in alcohol metabolism. 
The total phenolic and flavonoidal content of the extract, ECME was 
found to be 44.53±2.11 and 13.56±1.29 mg of gallic acid and REs per 
gram of extract, respectively.
In vitro cytotoxic activity
The results are shown in Fig. 1. The inhibitory concentration 50% 
value of ECME was found to be 2249.87 µg/ml. In MTT assay, the cell 
viability was >85% up to a concentration of 1000 µg/ml. Therefore, 
the extract concentrations of 50, 100 and 200 µg/ml were selected to 
further evaluate the cytoprotective activity against ethanol-induced cell 
damage.
In vitro hepatoprotective activity of the extract, ECME
The results of the study are shown in Table 1. Ethanol is metabolized by 
alcohol dehydrogenase in liver. However, in conditions such as extract 
Table 1: In vitro hepatoprotective activity of ECME using HepG2 cell lines
Groups %Cell viability LDH ALT AST
Group I (control)
Normal control 98.51±1.1 133.33±4.11a 8.61±1.14a 11.61±1.03a
DMSO control (0.1% v/v) 95.61±1.04 141.11±3.34a 9.33±1.24a 13.14±1.02a
Silymarin control (100 µg/ml) 97.24±1.02 138.36±4.16a 8.93±1.25a 12.18±1.11a
ECME control (200 µg/ml) 96.11±1.08 140.31±3.76a 9.12±2.11a 13.06±1.24a
Group II (toxin treatment)
100 mM ethanol 31.27±1.02a 230.6±5.42a 36.38±2.15a 49.31±2.54a
Group III silymarin treatment
100 mM ethanol + silymarin (50 µg/ml) 78.31±1.81a 156.31±3.16a 15.17±2.14a 20.14±2.17a
100 mM ethanol + silymarin (100 µg/ml) 86.72±1.35a 144.23±4.32a 13.31±1.19a 18.36±1.33a
Group IV (ECME treatment)
100 mM ethanol + ECME (50 µg/ml) 52.15±1.01a 199.3±1.26a 29.61±2.35a 34.31±1.27a
100 mM ethanol + ECME (100 µg/ml) 60.16±1.52a 188.21±3.14a 25.64±2.31a 27.34±2.05a
100 mM ethanol + ECME (200 µg/ml) 69.33±2.03a 179.24±4.43a 20.4±2.18a 24.36±2.67a
Data represent mean±SD (n=6). p value - Normal versus other groups; ap<0.01, bp<0.05. ECME: Methanolic extract of Echinochloa colona, SD: Standard deviation, 
AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, LDH: Lactate dehydrogenase, DMSO: Dimethyl sulfoxide
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have some functions in preserving the structural integrity of cellular 
membrane alcohol abuse, the microsomal electron transport system also 
participates in ethanol oxidation through cytochrome P 450 (2E1, 1A2, 
and 3A4 isoforms) isoenzyme, which generates free radicals causing 
cell damage [11]. Treatment with ethanol (100 mM), alone caused a 
drastic decrease in cell viability, i.e., 31.27±1.02% viability. Inoculation 
of ethanol increased the levels of AST, ALT, and LDH indicating damage 
to the cell plasma membrane as these enzymes are normally present 
in cytoplasm [12]. Treatment with ECME at 50, 100, and 200 µg/ml 
significantly reduced the elevated level of these enzymes in ethanol treated 
rats. This reflects that the extract have some functions in preserving 
structural integrity of hepatocellular membrane thus prevented the 
leakage of enzymes. The extract, ECME has shown a dose-dependent 
cytoprotective activity with maximum protection at 200 µg/ml.
CONCLUSION
The reason behind the protective effect of extract may be due to 
its ability to scavenge-free radicals that are produced during the 
metabolism of ethanol in HepG2 cells. The antioxidant principles such 
as flavonoids and phenolic compounds present in the extract, ECME 
contribute to the hepatoprotective activity of the extract. Further, the 
findings of the study substantiate the usage of the plant in traditional 
medicine for the treatment of jaundice.
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Fig. 1: In vitro cytotoxic activity of methanolic extract of 
Echinochloa colona
